Compound Detail
CHEMBL4792916
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1ccccc1/C=N/NC(=O)c1cc2cc(Nc3cc(C)nc4c(OC)cccc34)ccc2[nH]1
Basic Information
| ChEMBL ID | CHEMBL4792916 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QLNUODXZCZHDGS-MUFRIFMGSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
479.5
MW (Da)
5.55
ALogP
6
HBA
3
HBD
100.6
PSA (Ų)
0.21
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.68
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 2100.0 | nM | 5.68 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 32717483 |
| QGY-7703 | IC50 | = | 3400.0 | nM | 5.47 | Antiproliferative activity against human QGY-7703 cells assessed as reduction in... | 32717483 |
| SMMC-7721 | IC50 | = | 4580.0 | nM | 5.34 | Antiproliferative activity against human SMMC-7721 cells assessed as reduction i... | 32717483 |
| L02 | IC50 | = | 5170.0 | nM | 5.29 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 32717483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32717483 | 10.1016/j.ejmech.2020.112608 | HepG2 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | QGY-7703 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | SMMC-7721 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | L02 | 1 |
Data from ChEMBL 36 via Core Engine